FDA Drug information
Bortezomib
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Bortezomib BORTEZOMIB 1 mg/1 FOSUN PHARMA USA INC
- BORTEZOMIB BORTEZOMIB 1 mg/1 Hospira, Inc.
- Bortezomib BORTEZOMIB 1 mg/mL Fresenius Kabi USA, LLC
- BORTEZOMIB BORTEZOMIB 1 mg/mL Zydus Lifesciences Limited
- BORTEZOMIB BORTEZOMIB 1 mg/mL Zydus Pharmaceuticals USA Inc.
- Bortezomib BORTEZOMIB 2.5 mg/1 FOSUN PHARMA USA INC
- BORTEZOMIB BORTEZOMIB 2.5 mg/1 Hospira, Inc.
- BORTEZOMIB BORTEZOMIB 3.5 mg/1 Baxter Healthcare Corporation
- BORTEZOMIB BORTEZOMIB 3.5 mg/1 Baxter Healthcare Corporation
- Bortezomib BORTEZOMIB 3.5 mg/1 BluePoint Laboratories
- Bortezomib BORTEZOMIB 3.5 mg/1 BluePoint Laboratories
- BORTEZOMIB BORTEZOMIB 3.5 mg/1 Eugia US LLC
- Bortezomib BORTEZOMIB 3.5 mg/1 Fresenius Kabi USA, LLC
- Bortezomib BORTEZOMIB 3.5 mg/1 Hikma Pharmaceuticals USA Inc.
- Bortezomib BORTEZOMIB 3.5 mg/1 Hospira, Inc.
- Bortezomib BORTEZOMIB 3.5 mg/1 Ingenus Pharmaceuticals, LLC
- Bortezomib BORTEZOMIB 3.5 mg/1 Meitheal Pharmaceuticals Inc.
- Bortezomib BORTEZOMIB 3.5 mg/1 Qilu Pharmaceutical Co., Ltd.
- BORTEZOMIB BORTEZOMIB 3.5 mg/1 Sagent Pharmaceuticals
- Bortezomib BORTEZOMIB 3.5 mg/1 Sandoz Inc
- Bortezomib BORTEZOMIB 3.5 mg/3.5mL BluePoint Laboratories
- Bortezomib BORTEZOMIB 3.5 mg/3.5mL Sintetica US LLC
- Bortezomib BORTEZOMIB 3.5 mg/3.5mL Sintetica US LLC
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.